RE:RE:RE:RE:Business of Biotech Podcast with Matt Coffey - a MUST listenI agree, Capitalista. Probes opinion is just that, and many may disagree with his assessment. Remember that PFE has had real-time access to Bracelet data for the length of the trial and know what Onc has in Pela. The hold-up, in my opinion, is that they not only have to spend billions for pela/mBC, but now billions more for pela/pancreatic. PFE & Roche may just be in the midst of a bidding war with each other and Merck. IMHO, the winning bid will be announced in March sometime, and the deal finalized in & around the June ASCO & AGM. The acquiring BP can present the Bracelet data along with Matt. All my opinion.